PubRank

T A Walter

Author PubWeight™ 11.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Atypical chronic myelogenous leukemia in a patient with trisomy 8 mosaicism syndrome. Ann Hematol 1993 0.87
2 Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine. Hepatogastroenterology 1986 0.86
3 Efficacy of continuous therapy for peptic ulcer in controlled clinical trials. Aliment Pharmacol Ther 1993 0.82
4 Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia. Ann Hematol 1992 0.81
5 Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome. Cancer Genet Cytogenet 1989 0.80
6 Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients. Ann Hematol 1992 0.80
7 [H2 receptor antagonists and intragastric acidity]. Dtsch Med Wochenschr 1984 0.79
8 Effects of 800 mg cimetidine once daily on gastric acid secretion. Scand J Gastroenterol Suppl 1986 0.79
9 [Etintidine versus ranitidine: a single evening dose in the treatment of duodenal ulcer]. Dtsch Med Wochenschr 1984 0.79
10 The 24-hour acid suppression profile of nizatidine. Scand J Gastroenterol Suppl 1987 0.78
11 3p involvement in a renal cell carcinoma in von Hippel-Lindau syndrome. Region of tumor breakpoint clustering on 3p? Cancer Genet Cytogenet 1988 0.78
12 Overshadowing effects in the stimulus control of morphine analgesic tolerance. Behav Neurosci 1983 0.78
13 An ovarian thecoma with a single numerical aberration: +12. Cancer Genet Cytogenet 1993 0.78
14 [Inhibition of acid secretion in smokers caused by the new imidazole-H2-receptor antagonist etintidine]. Dtsch Med Wochenschr 1985 0.77
15 Lansoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion. Aliment Pharmacol Ther 1997 0.76
16 Nizatidine (300 mg nocte) does not interfere with diazepam pharmacokinetics in man. Br J Clin Pharmacol 1987 0.76
17 What are the current possibilities in treating peptic ulcer disease? Aliment Pharmacol Ther 1987 0.75
18 Famotidine: proven once-a-day treatment for gastric ulcer. Scand J Gastroenterol Suppl 1987 0.75
19 [The action of various doses of the new imidazole H2-receptor antagonist etintidine on intragastric acidity in man]. Arzneimittelforschung 1986 0.75
20 [Anti-ulcer agents. Clinico-experimental findings]. Med Welt 1984 0.75
21 [Are 2 tablets of magaldrate at bedtime effective in the therapy of duodenal ulcer?]. Dtsch Med Wochenschr 1985 0.75
22 [The role of H2 antagonists in Zollinger-Ellison syndrome]. Clin Ter 1984 0.75
23 [Intragastric acidity under the prostaglandin E2 analog trimoprostil. Increased inhibitory effect through administration after meals]. Arzneimittelforschung 1986 0.75
24 Increasing the yield of harvested bone marrow cells by raising room temperature during marrow collection. Exp Hematol 1995 0.75
25 Rioprostil 600 micrograms nocte: high duodenal ulcer healing rates and low incidence of side effects. Adv Prostaglandin Thromboxane Leukot Res 1987 0.75
26 [Smoking and peptic ulcer disease]. Fortschr Med 1986 0.75
27 Intragastric acidity under 28-day omeprazole treatment. Hepatogastroenterology 1985 0.75
28 Famotidine: nocturnal administration for gastric ulcer healing. Results of multicenter trials in Austria and Germany. Digestion 1985 0.75
29 Inversion of chromosome 5 long arm in region of cell growth gene cluster in hematologic disorders. Cancer Genet Cytogenet 1988 0.75
30 Night-time rioprostil versus ranitidine in duodenal ulcer healing. Lancet 1986 0.75
31 [Accelerated healing of ulcus ventriculi by a single evening dose of famotidine. Results of an Austrian-German-Italian multicenter study]. Schweiz Med Wochenschr 1985 0.75
32 [A single night-time dose of H2 antagonists: a novelty in the treatment of duodenal ulcer]. Clin Ter 1985 0.75
33 [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man]. Z Gastroenterol 1986 0.75
34 Rioprostil 600 micrograms nocte: high duodenal ulcer healing rates, low incidence of side effects. Prog Clin Biol Res 1987 0.75
35 Nocloprost, a novel prostanglandin E2 analog: significant reduction of aspirin induced grastrointestinal lesions in man. Prog Clin Biol Res 1987 0.75
36 Treatment of metastatic gastric carcinoma with a modified FAMTX chemotherapy regimen. Onkologie 1990 0.75